Mabpharm Limited (HKG:2181)

Mabpharm Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	93.33	109.26	89.34	173.35	33.57	81.56
Trading Asset Securities	-	-	-	-	15.04	-
Cash & Short-Term Investments	93.33	109.26	89.34	173.35	48.61	81.56
Cash Growth	-0.89%	22.29%	-48.46%	256.59%	-40.39%	-83.18%
Accounts Receivable	150.47	155.06	94.53	19.42	9.53	0.79
Other Receivables	3.34	3.48	9.2	23.97	30.66	41.47
Receivables	153.81	158.54	103.73	43.39	40.2	42.27
Inventory	145.01	136.56	111.01	102.04	100.8	53.21
Restricted Cash	-	-	39.34	-	-	-
Other Current Assets	29.64	29.94	22.35	23.43	11.52	70.74
Total Current Assets	421.79	434.3	365.77	342.21	201.12	247.77
Property, Plant & Equipment	541.72	568.99	614.25	686.54	704.01	561.05
Long-Term Deferred Tax Assets	52.97	52.97	-	-	-	-
Long-Term Deferred Charges	-	96.26	33.35	-	-	-
Other Long-Term Assets	12.34	0.94	2.85	6.23	12.39	91.09
Total Assets	1,169	1,153	1,016	1,035	917.52	899.9

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	41.2	30.17	11.71	10.03	16.77	60.09
Accrued Expenses	59.28	53.75	36.1	47.25	54.73	57.9
Short-Term Debt	-	-	-	-	-	0.74
Current Portion of Long-Term Debt	130.11	210.13	80.05	108.26	-	-
Current Portion of Leases	27.44	23.6	17.21	17	13.29	9.28
Current Income Taxes Payable	9.61	11.32	0.63	0.66	0.94	1.2
Current Unearned Revenue	55.83	56.39	45.5	40.28	26.6	37.93
Other Current Liabilities	180.12	148.69	120.93	92.72	76.07	67.87
Total Current Liabilities	503.59	534.04	312.13	316.19	188.4	235
Long-Term Debt	125.32	66.29	184.04	123.97	129.71	-
Long-Term Leases	25.08	26.72	30.29	33.35	28.34	36.41
Long-Term Unearned Revenue	298.99	321.82	351.95	308.03	122.43	26.51
Other Long-Term Liabilities	21.81	47.28	48.88	48.38	47.7	-
Total Liabilities	974.79	996.16	927.28	829.92	516.58	297.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.8	2.8	2.8	2.8	2.8	2.8
Additional Paid-In Capital	1,401	1,401	1,401	1,401	1,401	1,401
Retained Earnings	-1,272	-1,303	-1,361	-1,233	-1,023	-812.5
Comprehensive Income & Other	62.66	57.48	46.25	34.42	20.95	11.17
Total Common Equity	193.84	157.3	88.93	205.06	400.94	601.98
Shareholders' Equity	193.84	157.3	88.93	205.06	400.94	601.98
Total Liabilities & Equity	1,169	1,153	1,016	1,035	917.52	899.9

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	307.94	326.74	311.59	282.57	171.34	46.43
Net Cash (Debt)	-214.61	-217.48	-222.25	-109.23	-122.73	35.13
Net Cash Growth	-	-	-	-	-	-92.10%
Net Cash Per Share	-0.05	-0.05	-0.05	-0.03	-0.03	0.01
Filing Date Shares Outstanding	4,124	4,124	4,124	4,124	4,124	4,124
Total Common Shares Outstanding	4,124	4,124	4,124	4,124	4,124	4,124
Working Capital	-81.8	-99.74	53.65	26.02	12.72	12.77
Book Value Per Share	0.05	0.04	0.02	0.05	0.10	0.15
Tangible Book Value	54.04	157.3	88.93	205.06	400.94	601.98
Tangible Book Value Per Share	0.01	0.04	0.02	0.05	0.10	0.15
Buildings	-	198.29	198.29	198.21	117.92	117.92
Machinery	-	396.66	389.32	357.53	335.14	280.95
Construction In Progress	-	128.66	125.3	167.23	239.12	98.4
Leasehold Improvements	-	82.14	79.09	78.79	78.79	78.63

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 18, 2026

Data Sources Report a data error